Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Date: January 31, 2014
Pages: 39
Price:
US$ 1,500.00 US$ 1,125.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A25968C4398EN
Leaflet:

Download PDF Leaflet

Global Market Direct’s pharmaceuticals report, “Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014” provides data on the Avanir Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Avanir Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Avanir Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Avanir Pharmaceuticals, Inc. - Brief Avanir Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Avanir Pharmaceuticals, Inc. human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Avanir Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Avanir Pharmaceuticals, Inc.’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Evaluate Avanir Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Avanir Pharmaceuticals, Inc. in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Avanir Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Avanir Pharmaceuticals, Inc..
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Avanir Pharmaceuticals, Inc. and identify potential opportunities in those areas.
Avanir Pharmaceuticals, Inc. Snapshot
Avanir Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Avanir Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Avanir Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Avanir Pharmaceuticals, Inc. - Pipeline Products Glance
Avanir Pharmaceuticals, Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Avanir Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Avanir Pharmaceuticals, Inc. - Drug Profiles
(dextromethorphan hydrobromide + quinidine sulfate)
  Product Description
  Mechanism of Action
  R&D Progress
sumatriptan succinate
  Product Description
  Mechanism of Action
  R&D Progress
AVP-786
  Product Description
  Mechanism of Action
  R&D Progress
Avanir Pharmaceuticals, Inc. - Pipeline Analysis
Avanir Pharmaceuticals, Inc. - Pipeline Products by Therapeutic Class
Avanir Pharmaceuticals, Inc. - Pipeline Products by Target
Avanir Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
Avanir Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
Avanir Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
Avanir Pharmaceuticals, Inc. - Recent Pipeline Updates
Avanir Pharmaceuticals, Inc. - Dormant Projects
Avanir Pharmaceuticals, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
AVP-13358
AZD-2479
Avanir Pharmaceuticals, Inc. - Company Statement
Avanir Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Avanir Pharmaceuticals, Inc., Key Information
Avanir Pharmaceuticals, Inc., Key Facts
Avanir Pharmaceuticals, Inc. - Pipeline by Indication, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014
Avanir Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014
Avanir Pharmaceuticals, Inc. - Combination Treatment Modalities in Pipeline, 2014
Avanir Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2014
Avanir Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2014
Avanir Pharmaceuticals, Inc. - Phase III, 2014
Avanir Pharmaceuticals, Inc. - Phase II, 2014
Avanir Pharmaceuticals, Inc. - Phase I, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Therapeutic Class, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Target, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014
Avanir Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014
Avanir Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014
Avanir Pharmaceuticals, Inc. - Dormant Developmental Projects,2014
Avanir Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014

LIST OF FIGURES

Avanir Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014
Avanir Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014
Avanir Pharmaceuticals, Inc. - Combination Treatment Modalities in Pipeline, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Top 10 Therapeutic Class, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2014
Avanir Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2014
Avanir Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Skip to top


Ask Your Question

Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: